Page 109 - MBCA_FULL REPORT_FINAL_FOR_WEB

64. Irvin, W., Jr., H.B. Muss, and D.K. Mayer, Symptom management in metastatic breast cancer. Oncologist,
2011. 16(9): p. 1203-14.
65. Brothers, B.M. and B.L. Andersen, Hopelessness as a predictor of depressive symptoms for breast cancer
patients coping with recurrence. Psychooncology, 2009. 18(3): p. 267-75.
66. Charmaz, K., Good Days, Bad Days: The self in chronic illness and time. Vol. 1. 1991: Rutgers University Press.
324.
67. Bell, K. and S. Ristovski-Slijepcevic, Metastatic cancer and mothering: being a mother in the face of a
contracted future. Med Anthropol, 2011. 30(6): p. 629-49.
68. Griffiths, K.M., A.L. Calear, and M. Banfield, Systematic review on Internet Support Groups (ISGs) and
depression (1): Do ISGs reduce depressive symptoms? J Med Internet Res, 2009. 11(3): p. e40.
69. Lieberman, M.A., et al., Electronic support groups for breast carcinoma: a clinical trial of effectiveness.
Cancer, 2003. 97(4): p. 920-5.
70. Eysenbach, G., et al., Health related virtual communities and electronic support groups: systematic review
of the effects of online peer to peer interactions. BMJ, 2004. 328(7449): p. 1166.
71. Goodwin, P.J., et al., The effect of group psychosocial support on survival in metastatic breast cancer. N
Engl J Med, 2001. 345(24): p. 1719-26.
72. Northouse, L.L., D. Laten, and P. Reddy, Adjustment of women and their husbands to recurrent breast
cancer. Res Nurs Health, 1995. 18(6): p. 515-24.
73. Mayer, M., Lessons learned from the metastatic breast cancer community. Semin Oncol Nurs, 2010. 26(3):
p. 195-202.
74. Lazarus, R.S., Coping theory and research: past, present, and future. Psychosom Med, 1993. 55(3): p. 234-
47.
75. Fallowfield, L., et al., Identifying Barriers Preventing Clinical Trials Enrollment: Results of a Global Survey of
Patients with Metastatic Breast Cancer, in AACR Annual Conference. 2009: Denver, CO.
76. Gattellari, M., et al., When the treatment goal is not cure: are cancer patients equipped to make informed
decisions? J Clin Oncol, 2002. 20(2): p. 503-13.
77. Jenkins, V., L. Fallowfield, and J. Saul, Information needs of patients with cancer: results from a large study
in UK cancer centres. Br J Cancer, 2001. 84(1): p. 48-51.
78. Hack, T.F., et al., The communication goals and needs of cancer patients: a review. Psychooncology, 2005.
14(10): p. 831-45; discussion 846-7.
79. Harding, V., et al., ‘Being there’ for women with metastatic breast cancer: a pan-European patient survey.
Br J Cancer, 2013. 109(6): p. 1543-8.
80. Smith, M.L., et al., Preferences of patients with metastatic breast cancer., in 2011 ASCO Annual Meeting.
2011, Journal of Clinical Oncology: Chicago, IL.
81. Smith, M.L., et al., Examining patient choices for metastatic breast cancer drugs. , in 2012 ASCO Annual
Meeting. 2012, Journal of Clinical Oncology: Chicago, IL.
82. Cheville, A.L., et al., Prevalence and treatment patterns of physical impairments in patients with metastatic
breast cancer. J Clin Oncol, 2008. 26(16): p. 2621-9.
83. Portenoy, R.K. and P. Lesage, Management of cancer pain. Lancet, 1999. 353(9165): p. 1695-700.
84. Butt, Z., et al., Fatigue is the most important symptom for advanced cancer patients who have had
chemotherapy. J Natl Compr Canc Netw, 2008. 6(5): p. 448-55.

85. Hwang, S.S., et al., Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom
Manage, 2003. 26(1): p. 604-14.
109